Search

Author/Creator Durrant, Simon

1. Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy. (3rd January 2016)

Authors:
Mesa, Ruben; Verstovsek, Srdan; Kiladjian, Jean‐Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N.; Pane, Fabrizio; Zachee, Pierre; Zhen, Huiling; Jones, Mark M.; Parasuraman, Shreekant; Li, Jingjin; Côté, Isabelle; Habr, Dany; Vannucchi, Ales...
Journal:
European journal of haematology
Issue:
Volume 97:Number 2(2016:Aug.)
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide. (17th May 2017)

Authors:
Harrison, Claire N.; Griesshammer, Martin; Miller, Carole; Masszi, Tamas; Passamonti, Francesco; Zachee, Pierre; Durrant, Simon; Pane, Fabrizio; Guglielmelli, Paola; Verstovsek, Srdan; Jones, Mark M.; Hunter, Deborah S.; Sun, William; Li, Jingjin; Khan, Mahmudul; Habr, Dany; Kiladjian, Jean‐Jacques
Journal:
British journal of haematology
Issue:
Volume 182:Number 2(2018)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia. Issue 9 (29th July 2019)

Authors:
Dombret, Hervé; Topp, Max S.; Schuh, Andre C.; Wei, Andrew H.; Durrant, Simon; Bacon, Christopher Larry; Tran, Qui; Zimmerman, Zachary; Kantarjian, Hagop
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 9(2019)
Page Start:
2214
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study. Issue 3 (March 2020)

Authors:
Kiladjian, Jean-Jacques; Zachee, Pierre; Hino, Masayuki; Pane, Fabrizio; Masszi, Tamas; Harrison, Claire N; Mesa, Ruben; Miller, Carole B; Passamonti, Francesco; Durrant, Simon; Griesshammer, Martin; Kirito, Keita; Besses, Carlos; Moiraghi, Beatriz; Rumi, Elisa; Rosti, Vittorio; Blau, Igor Wolfga...
Journal:
Lancet
Issue:
Volume 7:Issue 3(2020)
Page Start:
e226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron). Issue 8 (12th August 2015)

Authors:
Ong, Sim Yee; Dolling, Lara; Dixon, Jeannette L; Nicoll, Amanda J; Gurrin, Lyle C; Wolthuizen, Michelle; Wood, Erica M; Anderson, Greg J; Ramm, Grant A; Allen, Katrina J; Olynyk, John K; Crawford, Darrell; Kava, Jennifer; Ramm, Louise E; Gow, Paul; Durrant, Simon; Powell, Lawrie W; Delatycki, Mar...
Journal:
BMJ open
Issue:
Volume 5:Issue 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effects of cognitive behavioural therapy on insomnia in adults with tinnitus: Systematic review and meta-analysis of randomised controlled trials. (April 2021)

Authors:
Curtis, Ffion; Laparidou, Despina; Bridle, Chris; Law, Graham R.; Durrant, Simon; Rodriguez, Alina; Pierzycki, Robert H.; Siriwardena, Aloysius N.
Journal:
Sleep medicine reviews
Issue:
Volume 56(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. (November 2016)

Authors:
Swords, Ronan T.; Greenberg, Peter L.; Wei, Andrew H.; Durrant, Simon; Advani, Anjali S.; Hertzberg, Mark S.; Lewis, Ian D.; Rivera, Gabriel; Gratzinger, Dita; Fan, Alice C.; Felsher, Dean W.; Cortes, Jorge E.; Watts, Justin M.; Yarranton, Geoff T.; Walling, Jackie M.; Lancet, Jeffrey E.
Journal:
Leukemia research
Issue:
Volume 50(2016:Nov.)
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up. Issue 7 (28th April 2014)

Authors:
Gambacorti‐Passerini, Carlo; Brümmendorf, Tim H.; Kim, Dong‐Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi‐Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 7(2014:Jul.)
Page Start:
732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗